SR11237, >=98% (HPLC)

SR11237, >=98% (HPLC)

Application

SR11237 may be used in RXR-mediated cell signaling studies.

Biochem/physiol Actions

SR11237 and other ligands of retinoid X receptor (RXR) activate various nuclear receptors during development process. This produces malformations in Xenopus embryos, involving the anterior-posterior axis.1

SR11237 is a selective pan retinoid X receptor (RXR) agonist with no retinoid A receptor (RAR) activity.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573933 SR11237, >=98% (HPLC) white to off-white 100 ZZUKALQMHNSWTK-UHFFFAOYSA-N 1S/C24H28O4/c1-22(2)11-12-23(3,4)20-15-18(9-10-19(20)22)24(27-13-14-28-24)17-7-5-16(6-8-17)21(25)26/h5-10,15H,11-14H2,1-4H3,(H,25,26) SIGMA-ALDRICH DMSO: >28 mg/mL (warmed) powder ≥98% (HPLC)
£596.14 (exc VAT) per 25MG
-
+
3573934 SR11237, >=98% (HPLC) white to off-white 100 ZZUKALQMHNSWTK-UHFFFAOYSA-N 1S/C24H28O4/c1-22(2)11-12-23(3,4)20-15-18(9-10-19(20)22)24(27-13-14-28-24)17-7-5-16(6-8-17)21(25)26/h5-10,15H,11-14H2,1-4H3,(H,25,26) SIGMA-ALDRICH DMSO: >28 mg/mL (warmed) powder ≥98% (HPLC)
£164.36 (exc VAT) per 5MG
-
+